logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
Showing 1 - 6 of 6 Items
Showing 1 - 6 of 6 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

High sustained viral response rate in patients with hepatitis C using generic sofosbuvir and daclatasvir in Phnom Penh, Cambodia

Zhang M, O'Keefe D, Iwamoto M, Sann K, Kien A,  et al.
2020-05-02 • Journal of Viral Hepatitis
2020-05-02 • Journal of Viral Hepatitis
Safe and efficacious pan-genotypic direct-acting antiviral (DAA) regimens, such as sofosbuvir and daclatasvir (SOF+DCV) facilitate simplified models of care for hepatitis C virus (HCV). ...
Journal Article
|
Research

Cost and cost-effectiveness of a simplified treatment model with direct-acting antivirals for chronic hepatitis C in Cambodia

Walker JG, Mafirakureva N, Iwamoto M, Campbell L, Kim CS,  et al.
2020-05-31 • Liver International
2020-05-31 • Liver International
BACKGROUND & AIMS
In 2016, Médecins Sans Frontières established the first general population Hepatitis C virus (HCV) screening and treatment site in Cambodia, offering free direct-ac...
Journal Article
|
Research

Molecular epidemiology of hepatitis C virus in Cambodia during 2016–2017

Nouhin J, Iwamoto M, Prak S, Doussett JP, Phon K,  et al.
2019-05-13 • Scientific Reports
2019-05-13 • Scientific Reports
In Cambodia, little epidemiological data of hepatitis C virus (HCV) is available. All previous studies were limited to only small or specific populations. In the present study, we perfor...
Journal Article
|
Research

Demonstration of the diagnostic agreement of capillary and venous blood samples, using hepatitis-C virus SD Bioline © rapid test: A clinic-based study

Sun C, Iwamoto M, Calzia A, Sreng B, Yann S,  et al.
2019-02-01 • Journal of Clinical Virology
2019-02-01 • Journal of Clinical Virology
BACKGROUND
Simplifying hepatitis C virus (HCV) screening is a key step in achieving the elimination of HCV as a global public health threat by 2030.

OBJECTIVES
The objec...
Journal Article
|
Research

Demonstration of the diagnostic agreement of capillary and venous blood T samples, using hepatitis-C virus SD Bioline rapid test: A clinic-based study

Sun C, Iwamoto M, Calzia A, Sreng B, Yann S,  et al.
2019-09-01 • Journal of Clinical Virology
2019-09-01 • Journal of Clinical Virology
BACKGROUND
Simplifying hepatitis C virus (HCV) screening is a key step in achieving the elimination of HCV as a global public health threat by 2030.

OBJECTIVES
The objec...
Journal Article
|
Research

Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia

Iwamoto M, Calzia A, Dublineau A, Rouet F, Nouhin J,  et al.
2018-12-03 • Journal of Viral Hepatitis
2018-12-03 • Journal of Viral Hepatitis
GeneXpert® (Cepheid) is the only WHO prequalified platform for hepatitis C virus (HCV) nucleic acid amplification testing that is suitable for point-of-care use in resource-limited conte...